Sunnyvale, CA, United States of America

Pamela H Christie

This inventor holds 1 USPTO granted patent. Top assignees: Sloan-Kettering Institute for Cancer Research, Sri International. Active years: 1988.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Pamela H Christie. Retrieved from https://idiyas.com/inventor/pamela-h-christie

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 1988

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Pamela H Christie

Introduction

Pamela H Christie is a notable inventor based in Sunnyvale, CA, who has made significant contributions to the field of chemistry. With a focus on the synthesis of diastereomers, her work has implications for cancer research and treatment.

Latest Patents

Christie holds a patent for "Diastereomers of 10-alkyl-10-deazaminopterins and process for preparing." This patent details the synthesis of individual d,L. and l,L.-diastereomers, highlighting that the d,L-10-ethyl diastereomer is three times as potent against L1210 cells compared to its l,L counterpart. Additionally, the l,L-10-ethyl diastereomer is noted to be approximately half as toxic as the d,L-10-ethyl diastereomer.

Career Highlights

Throughout her career, Christie has worked with esteemed organizations such as SRI International and the Sloan-Kettering Institute for Cancer Research. Her research has contributed to advancements in cancer treatment methodologies.

Collaborations

Christie has collaborated with notable colleagues, including Joseph I DeGraw and Francis M Sirotnak, further enhancing the impact of her work in the scientific community.

Conclusion

Pamela H Christie’s innovative work in the synthesis of diastereomers has made a significant impact in the field of cancer research. Her contributions continue to influence advancements in treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…